Literature DB >> 19153468

Structure of a highly stable mutant of human fibroblast growth factor 1.

Anna Szlachcic1, Małgorzata Zakrzewska, Daniel Krowarsch, Vibeke Os, Ronny Helland, Arne O Smalås, Jacek Otlewski.   

Abstract

Fibroblast growth factors (FGFs) are involved in diverse cellular processes such as cell migration, angiogenesis, osteogenesis, wound healing and embryonic and foetal development. Human acidic fibroblast growth factor (FGF-1) is the only member of the FGF family that binds with high affinity to all four FGF receptors and thus is considered to be the human mitogen with the broadest specificity. However, pharmacological applications of FGF-1 are limited owing to its low stability. It has previously been reported that the introduction of single mutations can significantly improve the stability of FGF-1 and its resistance to proteolytic degradation. Here, the structure of the Q40P/S47I/H93G triple mutant of FGF-1, which exhibits much higher stability, a prolonged half-life and enhanced mitogenic activity, is presented. Compared with the wild-type structure, three localized conformational changes in the stable triple mutant were observed, which is in agreement with the perfect energetic additivity of the single mutations described in a previous study. The huge change in FGF-1 stability (the denaturation temperature increased by 21.5 K, equivalent to DeltaDeltaG(den) = 24.3 kJ mol(-1)) seems to result from the formation of a short 3(10)-helix (position 40), an improvement in the propensity of amino acids to form beta-sheets (position 47) and the rearrangement of a local hydrogen-bond network (positions 47 and 93).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19153468     DOI: 10.1107/S0907444908039486

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  5 in total

1.  Probing the role of proline -135 on the structure, stability, and cell proliferation activity of human acidic fibroblast growth factor.

Authors:  Julie Eberle Davis; Arwa Alghanmi; Ravi Kumar Gundampati; Srinivas Jayanthi; Ellen Fields; Monica Armstrong; Vanessa Weidling; Varun Shah; Shilpi Agrawal; Bhanu Prasanth Koppolu; David A Zaharoff; Thallapuranam Krishnaswamy Suresh Kumar
Journal:  Arch Biochem Biophys       Date:  2018-07-19       Impact factor: 4.013

2.  A study of the activity and effectiveness of recombinant fibroblast growth factor (Q40P/S47I/H93G rFGF-1) in anti-aging treatment.

Authors:  Justyna Żerańska; Monika Pasikowska; Barbara Szczepanik; Krzysztof Mlosek; Sylwia Malinowska; Renata M Dębowska; Irena Eris
Journal:  Postepy Dermatol Alergol       Date:  2016-02-29       Impact factor: 1.837

Review 3.  Growth Factor Engineering Strategies for Regenerative Medicine Applications.

Authors:  Xiaochen Ren; Moyuan Zhao; Blake Lash; Mikaël M Martino; Ziad Julier
Journal:  Front Bioeng Biotechnol       Date:  2020-01-21

4.  Increased protein stability of FGF1 can compensate for its reduced affinity for heparin.

Authors:  Malgorzata Zakrzewska; Antoni Wiedlocha; Anna Szlachcic; Daniel Krowarsch; Jacek Otlewski; Sjur Olsnes
Journal:  J Biol Chem       Date:  2009-07-02       Impact factor: 5.157

5.  Effect of extension of the heparin binding pocket on the structure, stability, and cell proliferation activity of the human acidic fibroblast growth factor.

Authors:  Julie Eberle Davis; Ravi Kumar Gundampati; Srinivas Jayanthi; Joshua Anderson; Abigail Pickhardt; Bhanu Prasanth Koppolu; David A Zaharoff; Thallapuranam Krishnaswamy Suresh Kumar
Journal:  Biochem Biophys Rep       Date:  2017-12-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.